Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchghk-cucopper peptidegray market

NPR reports copper peptide use moving from creams to injections

The broadcast says GHK-Cu injection practice has outpaced the published evidence base for the copper tripeptide.

PR
By Priya Raman · Science Reporter
Sep 7 03:00 ETSource: NPR

The wire

  1. 01NPR describes a shift in copper peptide use from topical cosmetic formulations to injected GHK-Cu, framing the trend as running ahead of the science.
  2. 02GHK-Cu is widely sold through gray-market research-peptide channels, so clinicians and pharmacists may field patient questions about injected use.
  3. 03Only the headline summary is available here; no clinical data, adverse-event counts or regulatory action are described.

From the source

The copper peptide trend has gone from creams to injections — ahead of the science

Read at npr.org